Clinical Trial Update: A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial update on atezolizumab and Vigil in advanced gynecological cancers, including ovarian, cervical, and uterine cancers, with completed status and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Gynecological Cancers
• Ovarian Cancer
• Uterine Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Vigil

Snippet

Sponsor: Gradalis, Inc. | Conditions: Advanced Gynecological Cancers, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-04-05